tert-butyl (3S)-3-(1H-pyrazol-5-yl)azepane-1-carboxylate, 98%, 1g

5-Bromo-3-fluoro-2-hydroxybenzonitrile, 97%, 100mg

4-(4-CHLOROQUINAZOLIN-2-YL)-N,N-DIMETHYLANILINE, 95.0%, 1g

Carbonate de lithium, min 99 %, ultra pur, 500 g, emballage plastique.

(R)-(-)-NBD-Py-NCS [=(R)-(-)-4-(3-Isothiocyanatopyrrolidin-1-yl)-7-nitro-2,1,3-benzoxadiazole] [HPLC Labeling Reagent for e.e. Determination]>98.0%(HPLC)100mg

6-Methoxyisoquinoline, 95.0%, 5g

5-Amino-1H-indazole, 97%, 10g

6-Ethyl-4-methoxy-2-pyranone, 95.0%, 5g

1,2-Diphenylcyclopropane, 97%, 25g

2,3-DIMETHYL-6-IODO-2H-INDAZOLE, 95.0%, 250mg

4,4,5,5-Tetramethyl-2-(4-((3-(trifluoromethyl)benzyl)oxy)phenyl)-1,3,2-dioxaborolane, 98%, 100mg

3-(4-(1,2,2-Triphenylvinyl)phenyl)-1,10-phenanthroline, 98%, 1g

2-(2H-Benzo[d][1,2,3]triazol-2-yl)-4-(2,4,4-trimethylpentan-2-yl)phenol, 95.0%, 500g